The startup's asthma solution, called Mya, combines home-based diagnostics, digital health and a care team to identify patients at risk and proactively intervene to prevent asthma attacks.
With the information contained in a simple 30-second voice sample, providers can help patients get ahead of future health issues and prescribe or adjust treatment plans as needed.
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The company is using the funding to grow its product development and research teams, and expand the clinical services offered by its nurse support team. The Series C round was led by D1 Capital Partners and two new investors: the Medtech Convergence Fund and an undisclosed strategic investor.
The launch is the first in a planned series of personal health programs aimed at empowering older, at-risk patients to get healthy and prevent chronic diseases.
The overall collaboration is part of a state-funded pilot project at Texas A&M called Healthy South Texas, which focuses on preventing diabetes, asthma and infectious diseases in 27 counties in South Texas.
Randy Gutzke, a longtime IV drug user who says he struggles daily to stay sober, recently was offered a quick-results test for hepatitis C at a West Side community health center in Chicago. A case manager also reviewed the behaviors that put him at risk for contracting a hepatitis C infection, such as getting tattoos […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Ambio Health, a Stamford, Conn.-based company that specializes in health monitoring, received a Class II FDA 510(k) clearance for its Ambio Remote Health Monitoring System. With the intent of saving patients money, the device, which includes a wireless blood glucose monitor and wireless gateway (a blood pressure meter and weight scale, also FDA-approved, can be […]
By Michael Dunkley and James Wilson If there’s one thing we can always count on in the medical device world, it’s the steady beat of progress. We look for the big idea that will save lives, make doctors’ jobs easier and the medical field more efficient — thus saving costs. As designers, we keep our […]
For nearly a quarter century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that the benefits outweighed the risks -- especially when tiny, slow-growing tumors were detecte...
Corporate wellness programs get a lot of buzz for their potential to create healthier, more productive and less costly employees. But in a post over at The Health Care Blog, Al Lewis is taking jabs at some of those programs. Lewis, the president of Disease Management Purchasing Consortium International who and author of a book […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The tropical disease dengue fever isn’t something we hear or worry about much in the U.S. So when virologists at the Centers for Disease Control and Prevention recently published study findings that a rare 2010 dengue outbreak in Florida came not from abroad but from a unique, local strain of the virus that’s evolved its […]
While many large employers are going the route of on-site health clinics to save on health costs and encourage employees to become more engaged in their health, there are options for companies that can’t commit to a full, on-site clinic. One of those options is providing on-site preventive exams to their employees, and one company […]
Ten years ago, a landmark diabetes study funded by the National Institutes of Health delivered staggering results: Modest weight loss through dietary changes and increased physical activity could cut a prediabetic’s risk of developing the disease by 58 percent. Now fast forward to 2012, where a team of technologists, entrepreneurs and clinicians at Omada Health […]
A company developing prevention drugs for people with elevated risk for colon cancer is raising $5 million ahead of two pivotal trials. With its lead drug, Cancer Prevention Pharmaceuticals takes a two-pronged approach to preventing cancer by pairing CPP-1X/sul (Eflornithine) with the NSAID sulindac. Together these drugs interfere with two key pathways associated with cancer […]
Imagine a person that develops an acute problem that requires hospitalization and even a time in the ICU. Serious but something that modern medical care can deal with and cure. Until …the patient now develops an unexpected serious infection and despite excellent and appropriate medical care, dies. Unfortunately this scenario is all too common in […]